Navigation Links
Sangamo BioSciences to Acquire Ceregene
Date:8/26/2013

RICHMOND, Calif., Aug. 26, 2013 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that it signed a definitive agreement to acquire Ceregene, Inc., a privately held biotechnology company focused on developing adeno-associated virus (AAV) gene therapies.  Sangamo will host a teleconference at 8:30 am ET tomorrow, Tuesday, August 27, 2013, to discuss the acquisition and provide a general business overview.

(Logo: http://photos.prnewswire.com/prnh/20130102/SF35903LOGO)

"Ceregene is a leader in development and manufacturing of AAV-based therapies with significant clinical development experience," said Edward Lanphier, Sangamo's president and CEO.  "Since their inception in 2001, the company has safely treated over 115 subjects in four clinical trials. Sangamo has acquired all of Ceregene's AAV assets including CERE-110, AAV delivery of nerve growth factor (NGF) to the brain for the treatment of Alzheimer's disease.  CERE-110 is being evaluated in a fully enrolled and fully funded Phase 2 clinical trial. In addition to the AAV platform, the assets also include one of the world's largest databases of AAV GMP manufacturing know-how, toxicology data, and safety data from their human clinical trials, which will be an invaluable resource as we advance our ZFP Therapeutics."

Under the terms of the definitive agreement Sangamo will issue to the stockholders of Ceregene 100,000 shares of Sangamo's common stock, which represents less than 0.2 percent of Sangamo's total shares outstanding.  In addition, Sangamo has agreed to make contingent earn-out payments to the stockholders of Ceregene based upon revenues generated from license or sales transaction of certain existing products of Ceregene.  The acquisition is
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Sangamo BioSciences Announces Notice Of Allowance For New Patent Application Covering Genome Modification Technology
2. Sangamo BioSciences Reports Second Quarter 2013 Financial Results
3. Sangamo BioSciences Announces Publication of First Demonstration of Inactivation of Extra Chromosome Responsible for Down Syndrome
4. Sangamo BioSciences Announces Second Quarter 2013 Conference Call And Webcast
5. Sangamo BioSciences Reports First Quarter 2013 Financial Results
6. Sangamo BioSciences Announces First Quarter 2013 Conference Call and Webcast
7. Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare Conference
8. Sangamo BioSciences Announces Presentation At 33rd Annual Cowen And Company Health Care Conference
9. Sangamo BioSciences Reports Fourth Quarter And Full Year 2012 Financial Results
10. Sangamo BioSciences to Webcast Analyst Briefing on Thursday, December 6, 2012
11. Sangamo BioSciences Reports Second Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , July 1, 2015 Precyse, a ... education, announced today that, as part of its long ... agreement to be acquired by investment firm Pamplona Capital ... equity investors, Altaris Capital Partners and NewSpring Capital, have ... 1999, has assisted nearly 5,000 healthcare facilities and systems ...
(Date:7/1/2015)... July 1, 2015  Echo Therapeutics, Inc. (NASDAQ: ... on non-invasive continuous glucose monitoring and associated technologies, ... completely re-designed corporate website echotx.com . Echo,s ... Echo,s technology and enhances the quality and availability ... better communicates to prospective customers and stakeholders what ...
(Date:7/1/2015)... FT LAUDERDALE, Florida , July 1, 2015 /PRNewswire/ ... manufacturer and marketer of innovative medical devices for the treatment ... it prevailed in a final opposition appeal hearing in the ... 482 - STENT HAVING HELICAL ELEMENTS (,482). The ,482 patent ... and has been upheld as a valid patent in amended ...
Breaking Medicine Technology:Precyse Enters into Acquisition Agreement with Pamplona Capital Management 2Precyse Enters into Acquisition Agreement with Pamplona Capital Management 3Echo Therapeutics Announces New Website Launch 2Echo Therapeutics Announces New Website Launch 3OrbusNeich Announces Favorable Ruling from the European Patent Office and Initiation of Litigation Against Terumo Corporation 2
... 2011 United Seating & Mobility (USM) is ... with Central Kentucky Mobility (CKM) to acquire and merge its ... Lexington, Louisville, as well as central, eastern and southern Kentucky. ... strengthens our position within a core market for us and ...
... users from Europe, Asia, the Middle East, North America ... Germany June 16-19 to participate in Elekta,s fifth European ... presentations and workshops given by Elekta users and company ... The Users, Conference was preceded by the Elekta Stereotactic ...
Cached Medicine Technology:Elekta European Users' Conference Attracts Top Minds in Cancer Management 2Elekta European Users' Conference Attracts Top Minds in Cancer Management 3
(Date:7/1/2015)... ... 01, 2015 , ... Trevor L. Williams, DMD holds a Bachelor of Science ... earning a Master’s degree in Microbiology. He graduated from the University of Florida College ... the Florida Dental Association and the Academy of General Dentistry. Dr. Williams was born ...
(Date:7/1/2015)... Houston, TEXAS (PRWEB) , ... July 01, 2015 ... ... firm and solution provider of IBM software products, announced today that it has ... companies for the integration, display and detailed analysis of data from multiple sources ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... mesothelioma compensation law has just published a top ten list they hope will ... report. Click here to read it now. , More than ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... Author Francesca Camp wasn’t always ... into her lap, so too did her support of the practice; a terrible car accident ... In her new book, “Do I Need It ? (And What if I Do?): ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... healthcare leadership solutions firm B. E. Smith, Tri-City Medical Center in ... executive with a proven record of leading organization-wide compliance adaptation efforts and growing ...
Breaking Medicine News(10 mins):Health News:Trevor L. Williams, D.M.D. Joins Enlow & Vance Dental Partners in Tampa, Florida 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 3Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 4Health News:New Report Identifies Top 10 Mesothelioma Research Priorities, According to Surviving Mesothelioma 2Health News:Francesca Camp’s New Book Unmasks Plastic Surgery Advice 2Health News:Tri-City Medical Center Hires New Chief Compliance Officer 2Health News:Tri-City Medical Center Hires New Chief Compliance Officer 3
... pregnancy -- "16 and Pregnant" and "Teen Mom" -- were ... pregnancy, while supporters said they discouraged it. A new ... The study, which will appear in the journal ... the high dropout rate associated with pregnancy among this demographic. ...
... , TUESDAY, May 22 (HealthDay News) -- The ... since 2006, a new study finds. Researchers said one ... death has become more commonplace, and many of those livers ... healthy enough to attempt a transplant. Another reason livers are ...
... part of the National Institutes of Health, has renewed ... University of California, San Diego. Over the next five ... on the molecular and genetic consequences of exposure to ... It is the third funding cycle for UC ...
... severe hypersensitivity reactions to the anti-HIV drug abacavir occur through ... that are attacked by the body,s immune system, according to ... , official journal of the International AIDS Society ... & Wilkins , a part of Wolters Kluwer Health ...
... Body-building and weight-loss products are the types of dietary supplements ... new study. Liver injury from medication is the main ... supplements -- which do not require a prescription and can ... by up to 40 percent of people in the United ...
... -- New Mexico has the highest rate of injury-related deaths ... rate, according to a new report. New Mexico,s rate ... about 36 per 100,000. Overall, the national rate of injury-related ... released by the Trust for America,s Health and the Robert ...
Cached Medicine News:Health News:Viewers' family background affects how they react to MTV shows 16 and Pregnant, Teen Mom 2Health News:Viewers' family background affects how they react to MTV shows 16 and Pregnant, Teen Mom 3Health News:U.S. Liver Transplants Declining 2Health News:UC San Diego Superfund Research Program receives $15 million grant renewal 2Health News:Reactions to HIV drug have autoimmune cause, reports AIDS journal 2Health News:Reactions to HIV drug have autoimmune cause, reports AIDS journal 3Health News:Body Building, Diet Supplements Linked to Liver Damage: Study 2Health News:Injury-Linked Deaths Vary Widely Among States 2
... Accutome Ultrasound Advent Pachymeter exceeds previous product ... ALK and other lamellar procedures, the measurement ... microns. High end range is 1000 microns ... care. Newly designed 55 angle probe ensures ...
Precision that fits in the palm of your hand and measures down to 125 microns, the Pocket Pachymeter is about 8" X 4" x 2" and really does fit in a lab coat pocket or briefcase....
15 segment Vertical Prism Bar provides 1, 2, 3, 4, 5, 6, 8, 10, 12, 14, 16, 18, 20, 25, 30 PD (Note: 30 PD is on the bar). 4447 xx Vertical Prism Bar....
Valleylab Surgistat II generator provides exceptional performance, reliability, and safety benefits in a compact, easy to use unit....
Medicine Products: